A case report of sodium azide-induced myopericarditis
Open Access
- 20 March 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (4) , ytae134
Abstract
Background: Sodium azide exposures are rare but can be lethal as the substance inhibits complex IV in the electron transport chain, blocking adenosine-triphosphate (ATP) synthesis. Sodium azide is mostly used as a propellant in vehicular airbags but is also used in laboratory, pharmacy, and industrial settings. No known antidote exists and its cardiotoxic effects are poorly described in the literature. Case summary: We describe the case of a 31-year-old patient with major depressive disorder presenting with altered mental status after ingestion of an unknown amount of sodium azide. Although initially chest pain free, she developed pleuritic chest pain 48 h after ingestion. This was accompanied by new diffuse ST elevations on the electrocardiogram and serum troponin elevations concerning for myopericarditis. Treatment was pursued with a 14-day course of colchicine resulting in complete symptom resolution within 4 days of treatment initiation. The patient’s transthoracic echocardiogram was only notable for a preserved left ventricular ejection fraction (LVEF). Discussion: Cardiac toxicity after sodium azide ingestion usually occurs days after ingestion and has been previously described in the forms of heart failure with reduced ejection fraction complicated by cardiogenic shock. We describe the first case of sodium azide-induced myopericarditis with a preserved LVEF treated with colchicine. Colchicine is an established treatment for pericarditis, but its inhibition of endocytosis, an ATP-dependent cellular function, could be mechanistically relevant to this case.Keywords
This publication has 10 references indexed in Scilit:
- Potential therapies for sodium azide intoxication; a case report and review of the literatureAcute Medicine Journal, 2022
- Sodium azide poisoning: a narrative reviewClinical Toxicology, 2021
- Update on myocarditis – what we know so far and where we may be headingEuropean Heart Journal: Acute Cardiovascular Care, 2020
- A Comparison of Potential Azide Antidotes in a Mouse ModelChemical Research in Toxicology, 2020
- Surviving a Massive Sodium Azide Poisoning with Toxic CardiomyopathyInternational Cardiovascular Forum Journal, 2015
- Endocytosis Inhibitors Prevent Poly(amidoamine) Dendrimer Internalization and Permeability across Caco-2 CellsMolecular Pharmaceutics, 2008
- A case of survival following high-dose sodium azide poisoningClinical Toxicology, 2007
- Fatal azide-induced cardiomyopathy presenting as acute myocardial infarctionThe American Journal of Cardiology, 1989
- THE IN VITRO INHIBITION OF CYTOCHROME OXIDASE BY AZIDE AND CYANIDEJournal of Biological Chemistry, 1948
- Inhibitors of Catalase ReactionNature, 1934